Lombard Odier Asset Management (Switzerland)’s Evolent Health EVH Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-340,000	Closed	-$11.1M	–	256
2024 Q1	$11.1M	Sell	340,000 -60,000	-15%	-$1.91M	0.78%	24
2023 Q4	$13.2M	Buy	400,000 +100,000	+33%	+$2.83M	1.77%	14
2023 Q3	$8.17M	Hold	300,000	–	–	1.32%	26
2023 Q2	$9.09M	Hold	300,000	–	–	1.29%	25
2023 Q1	$9.73M	Buy	+300,000	New	+$9.49M	0.85%	34
2022 Q2	–	Sell	-35,000	Closed	-$1.13M	–	325
2022 Q1	$1.13M	Buy	+35,000	New	+$916K	0.09%	128

Other funds holding EVH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s EVH Position: Q2 2024 in Review

Lombard Odier Asset Management (Switzerland) sold out of Evolent Health (EVH) in Q2 2024, closing a stake of 340,000 shares — an estimated $11.1M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in EVH in Q1 2022 and held it in 6 quarters. The position peaked at $13.2M in Q4 2023. 243 funds tracked by Wall St. Rank hold EVH as of Q2 2024.

Lombard Odier Asset Management (Switzerland) reported no remaining Evolent Health position as of Q2 2024 after selling out during the quarter.
Lombard Odier Asset Management (Switzerland) sold 340,000 Evolent Health shares in Q2 2024, an estimated $11.1M.
Lombard Odier Asset Management (Switzerland) first reported a position in Evolent Health in Q1 2022 and held it in 6 quarters.
Lombard Odier Asset Management (Switzerland)'s Evolent Health position peaked at $13.2M in Q4 2023.
243 funds tracked by Wall St. Rank held Evolent Health as of Q2 2024.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2024, filed 14 Aug 2024.